fda changes tirzepatide confirms shortage is still over, gives compounders a grace period June/July 2026 Changes to Tirzepatide

FDA approval for its generic version of Saxenda (liraglutide injection), indication for weight loss

Currently, most GLP-1 medications are patent-protected, which means other companies cannot manufacture them, and there are no competitors

Ldemann, C

Mounjaro is on the fast-track to be approved for weight loss

d-Carnitine also increased the anaerobic production of lactic acid and d-citramalic acid from pyruvate, but was associated with reductions in the concentrations of five essential amino acids in tilapia (Leu, Val, Met, Trp and Phe) and higher concentrations of His and (+)-threo-2-amino-3,4-dihydroxybutanoic acid

Over 40% of older adults have obesity